Isordil Titradose (Isosorbide Dinitrate)

Isosorbide dinitrate is converted in the body to nitric oxide, a potent vasodilator. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels in smooth‑muscle cells. This cascade causes relaxation of arterial and venous walls, lowering preload and afterload, and consequently decreasing myocardial oxygen consumption.

The dosage of Isordil Titradose is individualized by the prescribing clinician. Treatment typically begins with a low oral dose that is gradually increased based on the patient’s response and tolerance. Exact dosing schedules and strengths should follow the prescriber’s instructions.

Safety data for isosorbide dinitrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers must assess each case and discuss potential risks with the patient.

To place an order, submit an enquiry on the Isordil Titradose product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details, and any necessary import documentation.

Isordil Titradose (isosorbide dinitrate) offers a longer duration of action compared with short‑acting nitrates like nitroglycerin, allowing for less frequent dosing. It provides consistent vasodilation and is often used for chronic management, whereas nitroglycerin is typically reserved for acute relief of angina attacks.

Store Isordil Titradose at room temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat, and direct sunlight. Do not store in a refrigerator or freezer unless otherwise directed by the manufacturer.

Isordil Titradose is taken orally as a tablet. Swallow the tablet whole with a glass of water; it may be taken with or without food. Follow the prescriber’s dosing schedule and avoid crushing or chewing the tablet unless instructed otherwise.

The most serious risks include severe hypotension, which can lead to fainting or shock, and syncope. Abrupt discontinuation may precipitate a rebound increase in angina or myocardial infarction. Rarely, allergic reactions or methemoglobinemia can occur and require immediate medical attention.

Isordil Titradose is contraindicated in patients with known hypersensitivity to isosorbide dinitrate or other organic nitrates, those with severe hypotension, and individuals who have recently used phosphodiesterase‑5 inhibitors. Caution is also advised for patients with certain cardiac conditions, such as recent myocardial infarction, unless directed by a physician.